Concentra Holdings Inc.: Takeaways from Management Meetings

Research evidence excerpt

Concentra Holdings Inc.: Takeaways from Management Meetings

J P M O R G A N North America Equity Research

18 June 2026

Concentra Holdings Inc. Overweight

CON, CON US

Takeaways from Management Meetings Price (17 Jun 26):$28.38

Managed Care and Facilities

Earlier this week, we hosted CON CFO Matt DiCanio and SVP of Finance & Benjamin Rossi AC

Strategy Tanner Newton in our offices. The discussions reinforced CON’s (1-212) 622-9603

favorable business momentum as we enter the summer months, and we were benjamin.rossi@jpmorgan.com

encouraged by mgmt’s commentary regarding the company’s durable rate growth, Lisa C. Gill

stable volume trends, Onsite opportunity with employers, potential whitespace in (1-212) 622-6466

NY should WC rate updates come through for next year, and capital deployment lisa.c.gill@jpmorgan.com

optionality as the company deleverages. Heading into 2Q, we flag CON as a John Stansel, CFA

compelling story with favorable growth drivers through location adds and (1-212) 622-0083

john.stansel@jpmorgan.com

extension of existing relationships with employers along with defensive

Cole Harris

characteristics vs sector peers possessing more challenging regulatory backdrops (1-212) 622-9068

and potential rate compression in Medicare/Medicaid. We also highlight CON’s cole.harris@jpmorgan.com

line of sight into the primary drivers factored into 2026 guidance and believe that J.P. Morgan Securities LLC

mgmt has set a reasonable bar for forward performance as the company executes

on its growth initiatives and benefits from a stable rate environment, consistent

demand, and steady expense trends. We reiterate CON as our top pick among

healthcare facilities given the company’s more de-risked topline growth algorithm,